Pharmaceutical-Biotech Capital Construction Investment Snapshot: Top 10 Projects Near $3 Billion for 2010
Pharmaceutical-Biotech Capital Construction Investment Snapshot: Top 10 Projects Near $3 Billion for 2010
Attachment: IIR Table - Top 10 U.S. Pharma-Biotech Projects
SUGAR LAND--April 15, 2010--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--With the economy still gyrating between growth and despair, it is gratifying to offer some positive news from the Pharmaceutical-Biotech Industry. As revealed by a recent analysis of active reported projects that are scheduled to begin construction in 2010, according to Industrial Info's Pharmaceutical Tracker - Online Database, the year's top 10 projects represent a total investment value (TIV) of $2.8 billion thus far. For this analysis, none of the referenced projects are sourced from the academic sector, and each carries an average TIV of $280 million.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.